Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Oct 20.
Published in final edited form as: Am J Med Genet A. 2007 Mar 15;143(6):538–545. doi: 10.1002/ajmg.a.31620

Interferon Regulatory Factor 6 (IRF6) and Fibroblast Growth Factor Receptor 1 (FGFR1) Contribute to Human Tooth Agenesis

Alexandre R Vieira 1,*, Adriana Modesto 2,3, Raquel Meira 4, Anna Renata Schneider Barbosa 3, Andrew C Lidral 5,6, Jeffrey C Murray 7
PMCID: PMC2570343  NIHMSID: NIHMS57340  PMID: 17318851

Abstract

Phenotypic characteristics expressed in syndromes give clues to the factors involved in the cause of isolated forms of the same defects. We investigated two genes responsible for craniofacial syndromes, FGFR1 and IRF6, in a collection of families with isolated tooth agenesis. Cheek swab samples were obtained for DNA analysis from 116 case/parent trios. Probands had at least one developmentally missing tooth, excluding third molars. In addition, we studied 89 cases and 50 controls from Ohio to replicate any positive findings. Genotyping was performed by kinetic polymerase chain-reaction or TaqMan assays. Linkage disequilibrium analysis and transmission distortion of the marker alleles were performed. The same variants in the IRF6 gene that are associated with isolated orofacial clefts are also associated with human tooth agenesis (rs861019, P = 0.058; rs17015215—V274I, P = 0.0006; rs7802, P = 0.004). Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. The craniofacial phenotypic characteristics of these syndromes include oral clefts and preferential tooth agenesis of incisors and premolars, besides pits on the lower lips. Also it appears that preferential premolar agenesis is associated with FGFR1 (P = 0.014) and IRF6 (P = 0.002) markers. There were statistically significant data suggesting that IRF6 interacts not only with MSX1 (P = 0.001), but also with TGFA (P = 0.03).

Keywords: hypodontia, oligodontia, cleft lip and palate, orofacial clefts, Kallmann syndrome, Van der Woude syndrome, PAX9, MSX1, TGFA, paired-box, muscle segment, transforming growth factor alpha

Introduction

The discovery of genes that are responsible for rare syndromes provides insights to the understanding of more common isolated traits. For facial anomalies, the genes for three rare autosomal syndromes were identified in recent years.

Loss-of-function mutations of fibroblast growth factor receptor 1 (FGFR1) cause Kallmann syndrome (OMIM 147950), which is characterized by an impaired sense of smell and incomplete or delayed puberty. Approximately 10% of individuals with Kallmann syndrome have mutations in the FGFR1 gene. Cleft lip and palate is associated in 30% of these cases and tooth agenesis in 5–10% of these cases [Dodé et al., 2003]. In addition, FGFR1 missense mutations cause two skeletal diseases, type I Pfeiffer syndrome (OMIM 101600) and osteoglophonic dysplasia (OMIM 166250). The altered FGFR1 protein appears to cause prolonged signaling, which promotes premature fusion of bones in the skull, hands, and feet in the case of Pfeiffer syndrome, and alters its function as negative regulator of long-bone growth in the case of osteoglophonic dysplasia [Muenke et al., 1994; White et al., 2005]. Finally, the t(8:9)(p11;q33) translocation fuses the centrosomal protein 1 (CEP1) in chromosome 11 and FGFR1 in chromosome 8 in the 8p11 myeloproliferative disorder. The demonstration that FGFR1 is disrupted by a translocation in a stem cell myeloproliferative disorder indicates that in addition to its involvement in Kallmann and Pfeiffer syndromes, it can also have oncogenic potential [Guasch et al., 2000].

Interferon regulatory factor 6 (IRF6) gene deletions and point mutations are responsible for Van der Woude (OMIM 119300) and popliteal pterygium syndromes (OMIM 119500) [Kondo et al., 2002]. In general, these syndromes affect about 1 in 100,000–200,000 people. About 1–2% of patients with cleft lip or palate have Van der Woude syndrome. Van der Woude syndrome is an autosomal dominant disorder in which lower-lip pits and less frequently tooth agenesis are the only features distinguishing the syndrome from isolated cleft lip with or without cleft palate (CL/P). CL/P occurs with wide geographic distribution with an average birth prevalence of 1 in 700 [Mossey and Little, 2002].

More recently, a significant association between CL/P and single nucleotide polymorphisms (SNPs) at the IRF6 locus was reported in a large collection of cases from many geographic origins [Zucchero et al., 2004] and replicated by four independent studies [Blanton et al., 2005; Ghassibe et al., 2005; Scapoli et al., 2005; Srichomthong et al., 2005]. Variation at IRF6 was responsible for 12% of the genetic contribution to CL/P and tripled the risk of recurrence in families that had already had one affected child. IRF6 is another gene in the list of candidate genes for CL/P that includes MSX1 and TGFA.

Similarly to CL/P, there is evidence that human tooth agenesis is a complex disorder with likely many genes involved. The frequency of tooth agenesis varies with the tooth class. Failure of one or more of the third molars to form occurs in 20% of the population. The reported incidence of teeth other than third molars being missing varies from 1.5 to 10% [Eidelman et al., 1973; Graber, 1978]. Autosomal dominant forms of oligodontia (agenesis of six or more teeth) have been linked to mutations or deletions in PAX9, MSX1 [reviewed by Vieira, 2003], and AXIN2 [Lammi et al., 2004]. One of the MSX1 mutations that affected a Dutch family [van den Boogaard et al., 2000] segregates with a combination of tooth agenesis, cleft lip and palate, and cleft palate only. This family presents the most compelling evidence that some of the same mechanisms are shared for the development of teeth, lip, and palate. Recently, we showed that MSX1 and TGFA, candidate genes for CL/P, are associated with tooth agenesis in humans and that MSX1 may interact with PAX9 [Vieira et al., 2004].

Additional evidence for common pathways in tooth, lip, and palate development comes from other studies that showed an association between having a cleft and tooth agenesis outside the cleft area, as well as studies that have shown that as clefting increases in severity, a greater number of teeth are missing [Ranta, 1984, 1988; Quezada et al., 1998; Ranta and Tulensalo, 1988; Lopes et al., 1991; Roth and Hirschfelder, 1991; Vichi and Franchi, 1995; Larson et al., 1998; Dewinter et al., 2003; Slayton et al., 2003]. In the present investigation, we examined samples of individuals with tooth agenesis to investigate the involvement of FGFR1 and IRF6—genes involved in forms of CL/P—in cases of tooth agenesis, an even more common craniofacial phenotype.

Subjects and Methods

Our study group consisted of 116 patients with tooth agenesis and their parents. All of them were from Rio de Janeiro, Brazil, which is an admixed population of Europeans (from Portugal) and Africans, with a very small percentage of Native South Americans. This population contains 71 sporadic cases and 45 familial cases. Tooth agenesis was the sole disorder affecting these patients. None of the families reported history for clefts. Details of the study population are presented in Table I. The study was approved by the appropriate Institutional Review Board (IRB) and appropriate informed consent was obtained from human subjects. After informed consent was obtained, cheek swabs were collected from each individual. Clinical analysis, check swab collection, and DNA extraction were performed using a consolidated protocol described elsewhere [Vieira et al., 2004]. Cases were analyzed not only as a total group, but also in three subgroups: cases with positive family history, cases with at least one missing incisor, and cases with at least one missing premolar. To facilitate comparisons between studies, we selected ten polymorphisms that had been used before to investigate IRF6 and CL/P populations [Zucchero et al., 2004]. Additional four polymorphisms were selected to study the FGFR1 gene. Marker information is included in Table II. Genotypes were obtained using an ABI PRISM 7900 Sequence Detection System (Valencia, CA) and TaqMan or SIBR Green chemistries. Reagents and SNP genotyping assays were supplied by Applied Biosystems (Valencia, CA). All SNPs showed Hardy–Weinberg equilibrium in both the affected and unaffected individuals. Pairwise calculations of linkage disequilibrium (Table III) were computed with the Graphical Overview of Linkage Disequilibrium (GOLD) software for both the squared correlation coefficient (r2, above the diagonal) and Lewontin's standardized disequilibrium coefficient (D′, below diagonal) [Abecasis and Cookson, 2000]. Alleles at each marker and haplotypes were tested for association with tooth agenesis with the use of the Family Based Association Test (FBAT) software [Horvath et al., 2001, 2004]. Bonferroni correction was applied and P-values below 0.003 (0.05/14) were considered significant.

Table I.

Aspects of the Population Studied

Family characteristic N (%)
Gender distribution
 Males 42 (36)
 Females 74 (64)
Average age of the probands (variation) 20 years (6–50 years)
Number of teeth missing
 1 44 (38)
 2 46 (40)
 3 or more 26 (22)
Type of teeth more often missing
 (total teeth missing = 274)
 Second premolar 104 (37.9)
 Lateral incisor 82 (29.9)
 First premolar 26 (9.7)
 Second molar 24 (8.7)
 Central incisor 16 (5.8)
 First molar 11 (4)
 Canines 11 (4)
Associated dental anomalies 16 (13.8)
Number of cases missing incisors 55 (47.4)
Number of cases missing premolars 63 (54.3)
Number of cases missing molars 14 (12)
Number of cases missing canines 7 (6)
Positive family history 41 (35.3)

Table II.

Information about Assays for SNP Analyzed in this Study

SNP marker Approximate location Type of assay Assay ID
FGFR1
 rs13317 In FGFR1 TaqMan ODa C_1358324_10
 rs6996321 In FGFR1 TaqMan OD C_2080144_10
 rs10958704 2 kb 5′ of FGFR1 TaqMan OD C_2080139_10
 rs881301 7 kb 5′ of FGFR1 TaqMan OD C_8844845_10
IRF6
 rs2073487 In IRF6 TaqMan OD C_2500179_1
 rs861019 In IRF6 TaqMan BDb NA
 rs764093 In IRF6 TaqMan OD C_2500165_10
 rs2235375 In IRF6 TaqMan BD NA
 rs17015215 (V274I) In IRF6 Kinetic PCR See below
 rs7802 In IRF6 TaqMan BD NA
 hCV16191297 60 kb 3′ of IRF6 TaqMan BD NA
 hCV2502441 90 kb 3′ of IRF6 TaqMan BD NA
 rs2235543 100 kb 3′ of IRF6 TaqMan BD NA
 hCV2501174 200 kb 3′ of IRF6 TaqMan BD NA

For V274I: Common primer sequence: CAGACCATGACCGTGAGCAA.

V-specific primer: TGCTCAGGACCTGGGAATTTGTC.

I-specific primer: TATGCTCAGGACCTGGGAATTTTTAT.

NA = not available.

a

Assay-on-demand.

b

Assay-by-design.

Table III.

Linkage Disequilibrium between Markers Genotyped in the Study

Marker rs2073487 rs861019 rs764093 rs2235375 rs17015215 (V274I) rs7802 hCV16191297 hCV2502441 rs2235543 hCV2501174
IRF6
rs2073487 0.041 0.412 0.093 0.034 0.0 0.072 0.0 0.013 0.004
rs861019 0.406 0.107 0.679 0.878 0.001 0.017 0.002 0.005 0.0
rs764093 0.714 0.684 0.168 0.111 0.003 0.047 0.022 0.009 0.013
rs2235375 0.669 0.963 1.0 0.595 0.003 0.033 0.0 0.028 0.002
rs17015215 (V274I) 0.375 0.985 0.732 0.853 0.047 0.039 0.001 0.005 0.0
rs7802 0.033 0.029 0.091 0.084 0.284 0.0 0.001 0.003 0.0
hCV16191297 0.591 0.581 0.439 1.0 1.0 0.037 0.007 0.005 0.004
hCV2502441 0.016 0.373 0.224 0.038 0.192 0.254 0.106 0.059 0.063
rs2235543 0.733 0.233 0.674 0.468 0.219 0.064 0.999 0.614 0.295
hCV2501174 0.085 0.027 0.178 0.075 0.006 0.042 0.993 0.586 0.548
Marker rs13317 rs6996321 rs10958704 rs881301
FGFR1
rs13317 0.105 0.036 0.059
rs6996321 0.484 0.450 0.373
rs10958704 0.430 0.979 0.787
rs881301 0.515 0.917 0.894

r2 is above the diagonal; D′ is below the diagonal.

To infer the overall contribution of IRF6 to human tooth agenesis, we calculated the attributable fraction (AF) for the associated IRF6 allele [V of the V274I (rs17015215) marker]—that is, the proportion of tooth agenesis cases in a population that can be attributed to the V allele. We calculated the AF according to the formula

AF=f(R1)1+f(R1)

where f is the frequency of the risk factor in the population [frequency of the associated haplotype composed by all 10 markers; f = 0.286 (data not shown)] and R is the measure of relative risk. We used the odds ratio of the proportion of transmitted and non-transmitted V274I (rs17015215) alleles (data not shown) as an estimate of the relative risk.

We also studied a population from Ohio, USA, to replicate any association between the FGFR1 and IRF6 locus and the tooth agenesis phenotype. Details about these samples are reported elsewhere [Lidral and Reising, 2002]. A total of 89 samples from individuals affected with congenital tooth agenesis recruited from the Ohio State University College of Dentistry and Children's Hospital in Columbus were used. Written consent was obtained from all individuals, and the study was approved by the Ohio State University IRB. The inclusion criterion was congenital agenesis of at least one permanent tooth, not including third molars, as verified by radiographs and dental history. In addition, 50 Caucasian controls from Ohio, who were not affected with tooth agenesis, were also recruited. Genotypes for the IRF6 marker rs764093 of the 89 tooth agenesis cases were compared to the 50 controls. This marker was chosen because it showed higher heterozygosity among Caucasians, compared to the markers V274I (rs17015215) and rs861019 [Zucchero et al., 2004]. We also studied the FGFR1 rs881301 marker, which showed evidence of association in the Brazilian dataset.

Finally, we tested for possible gene-gene interactions between the two genes studied (FGFR1 and IRF6) and other candidate genes for tooth agenesis using genotypes performed in the same Brazilian study population [Vieira et al., 2004]. We tested for FGFR1-IRF6, FGFR1-MSX1, FGFR1-PAX9, FGFR1-TGFA, IRF6-MSX1, IRF6-PAX9, and IRF6-TGFA interactions by observing the transmission of the marker alleles from parents heterozygous for both of the markers.

Results

Significant linkage disequilibrium with the IRF6 locus was apparent for the marker rs17015215 (V274I) (P = 0.0006) and borderline for the markers rs7802 and rs861019 (P = 0.004, and 0.058 respectively). The estimated AF for the associated IRF6 V274I (rs17015215) V allele was 16.4%.

Borderline results were found for the FGFR1 marker rs881301 (P = 0.03); in all these markers, the common allele was overtransmitted to the affected individuals (Table IV). While markers rs861019 and V274I (rs17015215) are in linkage disequilibrium, V274I (rs17015215) and rs7802 are only weakly linked (Table II). Haplotype analysis was performed with the HBAT function of FBAT, using windows of three adjacent SNPs across the IRF6 locus (Table V). Haplotypes carrying the frequent allele of the V274I (rs17015215) marker were always found to be overtransmitted to patients. No association was found when FGFR1 haplotypes were analyzed. When IRF6 V274I (rs17015215) was analyzed in cases with positive family history for tooth agenesis, cases with at least one missing incisor, and cases with at least one missing premolar, the association is apparent with the group that lacks premolars. The same was found for the FGFR1 rs881301 marker (Table VI).

Table IV.

Association (FBAT) Results for Isolated Tooth Agenesis

SNP Allele S E (S) P-value
FGFR1
 rs13317 T 92.0 89.5 0.547
C 36.0 38.5
 rs6996321 G 60.0 59.5 0.905
A 46.0 46.5
 rs10958704 A 69.0 72.5 0.458
G 67.0 63.5
 rs881301 T 39.0 32.0 0.030
C 25.0 32.0
IRF6
 rs2073487 A 70.0 64.0 0.163
G 40.0 46.0
 rs861019 A 10.0 7.5 0.058
G 2.0 4.5
 rs764093 G 72.0 68.0 0.358
T 44.0 48.0
 rs2235375 C 77.0 72.5 0.323
G 45.0 49.5
 rs17015215
(V274I)
V 91.0 75.0 0.0006
I 29.0 45.0
 rs7802 C 16.0 12.0 0.004
T 0.0 4.0
 hCV16191297 C 3.0 3.0 1.0
T 1.0 1.0
 hCV2502441 A 58.0 58.0 1.0
G 28.0 28.0
 rs2235543 T 72.0 72.0 1.0
C 32.0 32.0
 hCV2501174 A 53.0 52.0 0.772
T 27.0 28.0

Table V.

Haplotype Results for Sliding Three-Marker Window Across the IRF6 Region Studied

SNP

Window rs2073487 rs861019 rs764093 rs2235375 rs17015215 (V274I) rs7802 hCV16191297 hCV2502441 rs2235543 hCV2501174 Haplotype frequency P-value
1 A A G 0.63 0.053
2 A G C 0.63 0.094
3 G C V 0.49 0.005
4 C V C 0.51 0.002
5 V C C 0.74 0.001
6 C C A 0.77 0.490
7 C A T 0.72 0.476
8 A T A 0.63 0.330

Table VI.

IRF6 V274I and FGFR1 rs881301 Results (FBAT) for Subpopulations of Tooth Agenesis Cases

Subpopulation Allele S E (S) P-value
IRF6
 Positive family history for tooth agenesis (n = 45) V 33.0 29.5 0.262
I 17.0 20.5
 Missing at least one incisor (n = 55) V 39.0 34.5 0.149
I 15.0 19.5
 Missing at least one premolar (n = 63) V 54.0 43.0 0.002
I 16.0 27.0
FGFR1
 Positive family history for tooth agenesis (n = 45) T 18.0 14.0 0.073
C 14.0 18.0
 Missing at least one incisor (n = 55) T 19.0 16.667 0.282
C 15.0 17.333
 Missing at least one premolar (n = 63) T 23.0 17.0 0.014
C 13.0 19.0

No differences in allele and genotype frequencies were seen between tooth agenesis cases and unaffected controls from Ohio regarding the FGFR1 rs881301 and IRF6 rs764093 markers (Table VII).

Table VII.

Case-Control Analysis of the Ohio Tooth Agenesis Population

Alleles Controls (n = 50) Tooth agenesis cases (n = 89)
FGFR1 rs881301
 C 32 63
 T 44 97
P-value 0.68
 Odds ratio (95% confidence intervals) 1.12 (0.64–1.95)
Genotypes
 CC 4 15
 CT 24 33
 TT 10 32
P-value 0.08
 CC 4 15
 CT + TT 34 65
P-value 0.25
 Odds ratio (95% confidence intervals) 0.51 (0.16–1.66)
IRF6 rs764093
 G 66 112
 T 34 56
P-value 0.91
 Odds ratio (95% confidence intervals) 0.97 (0.57–1.64)
Genotypes
 GG 22 33
 GT 22 46
 TT 6 10
P-value 0.67
 GG + GT 44 79
 TT 6 10
P-value 0.89
 Odds ratio (95% confidence intervals) 0.93 (0.32–2.72)

The IRF6 V274I (rs17015215) V allele and the MSX1-CA 169-base-pair allele were transmitted together more often than expected (P = 0.001), as well as the IRF6 V274I (rs17015215) V allele and the TGFA common haplotype Taq1- rs2166975-rs1058213 (P = 0.03) (Table VIII).

Table VIII.

IRF6- and FGFR1-Other Candidate Genes for Tooth Agenesis Interactions

Interaction # Informative families T/NT P-value
IRF6-FGFR1 2 1/0a 0.31
IRF6-MSX1 32 12/1b 0.001
IRF6-PAX9 18 6/3c 0.30
IRF6-TGFA 21 10/2d 0.03
FGFR1-MSX1 18 4/2e 0.41
FGFR1-PAX9 5 3/0f 0.08
FGFR1-TGFA 7 3/1g 0.31

T = number of transmitted alleles; NT = number of non-transmitted alleles.

a

IRF6 V274I (rs17015215) V allele with FGFR1 rs881301 C allele.

b

IRF6 V274I (rs17015215) V allele with MSX1-CA 169-base-pair allele.

c

IRF6 V274I (rs17015215) V allele with PAX9 rs11847165 C allele.

d

IRF6 V274I (rs17015215) V allele with TGFA common haplotype Taq1-rs2166975-rs1058213.

e

FGFR1 rs881301 C allele with MSX1-CA 171-base-pair allele.

f

FGFR1 rs881301 T allele with PAX9 rs11847165 C allele.

g

FGFR1 rs881301 T allele with TGFA common haplotype Taq1-rs2166975-rs1058213.

Discussion

We found a significant association between a marker in the IRF6 gene and tooth agenesis in an admixed population from Brazil who is predominantly Caucasian with Portuguese ancestry. The estimated AF for the associated IRF6 marker allele was 16.4%. This AF is based on the assumption that the risk factor is causal and is not correlated with other risk factors, so it should be interpreted cautiously because the IRF6 contribution could happen in the background of other genes.

We also found a suggestive association between a marker in the FGFR1 gene and this same population.

We were unable to replicate these findings in a population from Ohio, the US, who is predominantly of Caucasian origin. However, they are Caucasians more likely to be descendents of Northern Europeans, which may suggest genetic heterogeneity. In our previous studies with IRF6 in cleft populations [Zucchero et al., 2004], we have also found only an effect in transmission-disequilibrium analyses and not in case-control comparisons. It may be an indication that much larger case-control studies are needed to find evidence of a genetic effect indicated by candidate-gene analysis and linkage disequilibrium.

It is remarkable that the same gene locus appears to contribute to phenotypes varying from very rare syndromic forms of clefting (frequency 1 to 100,000 to 200,000 live births) to the more common isolated forms of clefting (frequency 1 to 500 to 2,000) to the very common tooth agenesis phenotype (frequency 1 to 10 to 100) as these defects were part of the same clinical spectrum. Furthermore, 20–40% of the cases of Van der Woude syndrome present with tooth agenesis, preferentially involving incisors and premolars [Jones, 1997]. The relationship between premolar agenesis and clefting has been noted by previous studies [Larson et al., 1998], but its nature remains unclear. The association with cases lacking at least one premolar suggests that the IRF6 spectrum may include isolated forms of clefting and tooth agenesis with preferential missing premolars. We also found evidence that FGFR1 contributes to lacking premolars. These findings provide further evidence that human tooth agenesis is probably caused by several independent defective genes, acting alone or in combination with other genes, and leading to a specific phenotypic pattern.

We have reasons to believe that the V allele of the IRF6 V274I marker, which is significantly overtransmitted in the Brazilian dataset, does not itself cause tooth agenesis. There is strong disequilibrium seen between particular IRF6 haplotypes and cleft lip and palate in European populations [Zucchero et al., 2004], in which the I variant allele is rare. This suggests either that the V allele is not causal, or that it may share causality with variants at other sites within or near IRF6. It is possible that more than one variant might contribute to tooth agenesis or a specific combination of variants on a single chromosome may be required for a person to exhibit biologic effect (tooth agenesis or cleft lip and palate).

The occurrence of a mixed clefting phenotype in the same family (cleft lip and palate cases and cleft palate only cases) is common in families affected with Van der Woude syndrome, but very rare in families with isolated orofacial clefts, and is not seen in most other syndromic forms of orofacial clefts. It is, however, also seen in the cleft lip and palate-oligodontia disorder caused by a mutation in MSX1 [van den Boogaard et al., 2000] suggesting that IRF6 and MSX1 may be involved in a common genetic pathway. In support of a common pathway, Kondo et al. [2002] found two IRF binding sites in the promoter of MSX1 and one in the intron, all of which are conserved between human and mouse. In mice, high levels of Irf6 expression are observed in the hair follicles, palatal rugae, medial edge epithelia of the secondary palate immediately before and during fusion, tooth germs, thyroglossal duct, penis, and skin [Kondo et al., 2002]. According to the COGENE project (a consortium involved in describing human gene expression changes that occur during early stages of craniofacial development; http://hg.wustl.edu/COGENE/), IRF6, MSX1, and TGFA are expressed in the human mandible at 6 weeks of gestation and IRF6 and MSX1 are expressed in the human dental lamina at 8.5 weeks of gestation. Our results tied with the expression data are suggestive that interactions between IRF6 and MSX1 and IRF6 and TGFA or altered expression of these combinations of genes can lead to tooth agenesis in humans.

There are reports of a same gene family that contributes to both rare and more common traits. Mutations in COL11A1 and COL2A1 genes cause Marshall and Stickler syndromes, rare autosomal dominant disorders that affect cartilaginous tissues [Ahmad et al., 1991; Annunen et al., 1999a]. Also, an association between an allele of the COL9A2 gene bearing a putative mutation and intervertebral disc disease, a phenotype that can affect up to 5% of the Finn population, was reported [Annunen et al., 1999b]. It is likely that genes or gene families that cause other rare disorders also contribute to more common, but genetically complex phenotypes.

In summary, we reported that genetic variation in the IRF6 locus, which has been implicated in the rare Van der Woude and popliteal pterygium syndromes as well as in the more common isolated cleft lip with or without CL/P, is associated with human tooth agenesis, a complex trait that affects 1 in every 10–100 individuals. This association appears to be related to premolar agenesis. Also, a marker in FGFR1, in which mutations cause Kallmann syndrome, was associated with premolar agenesis. We believe that rare diseases can serve as models for genetic susceptibility of more common traits in the population.

Acknowledgments

We are very grateful to the families who enthusiastically participated in this study. We are also indebted to the colleagues who recommended their patients and helped with sample collection. In Brazil, Drs. Marcelo de Castro Costa, Laura Primo, Ivete Souza, Rogerio Gleiser, Maria Encarnação Requejo, Aline Neves, Mariana Passos, Paula Alcântara, Juliana Abdenur, Rodolfo Castro, Bianca Santiago, Lívia Soares, Cristina Lepecka, Marta Lua, Luciana Pomarico, Renata Simões, Maria Bárbara Guimarães, Daniela Della Valle, Osvaldo Costa, Roberta Barcelos, Cláudia Tavares, Silvia Malaquias, Valéria Teixeira, Rui Meira, Patrícia Mendes, and Liana Amado. In Ohio, Drs. Heather Abrahams, Mark Bentele, Alex Cassinelli, Dale Anne Featheringham, Jim Eimer, Brian Hockenberger, Ceil Markham, Ana Mercado, Elizabeth Peruchini, Robert Pham, Arnold Riesmeijer, Michelle Renick, Brenda Wilhelm, and Roger Zody. We thank Brian Schutte for critically reading this manuscript.

Grant sponsor: NIH; Grant numbers: DE 08559, DE 16215, D43 TW05503.

References

  1. Abecasis GR, Cookson WO. GOLD—graphical overview of linkage disequilibrium. Bioinformatiocs. 2000;16:182–183. doi: 10.1093/bioinformatics/16.2.182. [DOI] [PubMed] [Google Scholar]
  2. Ahmad NN, Ala-Kokko L, Knowlton RG, Jimenez SA, Weaver EJ, Maguire JI, Tasman W, Prockop DJ. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy) Proc Nat Acad Sci. 1991;88:6624–6627. doi: 10.1073/pnas.88.15.6624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Annunen S, Körkkö J, Czamy M, Warman ML, Brunner HG, Kääriäinen H, Mulliken JB, Tranabjaerg L, Brooks DG, Cox GF, Cruysberg JR, Curtis MA, Davenport SL, Friedrich CA, Kaitila I, Krawczynski MR, Latos-Bielenska A, Mukai S, Olsen BR, Shinno N, Somer M, Vikkula M, Zlotogora J, Prockop DK, Ala-Kokko L. Splicing mutations of 54 bp exons in the COL11A1 gene cause Marshall syndrome but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet. 1999a;65:974–983. doi: 10.1086/302585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Annunen S, Paassilta P, Lohiniva J, Perälä M, Pihlajamaa T, Karppinen J, Tervonen O, Kroger H, Lahde S, Vanharanta H, Ryhanen L, Goring HH, Ott J, Prockop DJ, Ala-Kokko L. An allele of COL9A2 associated with intervertebral disease. Science. 1999b;285:409–412. doi: 10.1126/science.285.5426.409. [DOI] [PubMed] [Google Scholar]
  5. Blanton SH, Cortez A, Stal S, Mulliken JB, Finnell RH, Hecht JT. Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet Part A. 2005;137A:259–262. doi: 10.1002/ajmg.a.30887. [DOI] [PubMed] [Google Scholar]
  6. Dewinter G, Quirynen M, Heidbüchel K, Verdonck A, Willems G, Carels C. Dental abnormalities, bone graft quality, and periodontal conditions in patients with unilateral cleft lip and palate at different phases of orthodontic treatment. Cleft Palate-Craniofac J. 2003;40:343–350. doi: 10.1597/1545-1569_2003_040_0343_dabgqa_2.0.co_2. [DOI] [PubMed] [Google Scholar]
  7. Dodé C, Levilliers J, Dupont JM, De Paepe A, Le Dû N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33:463–465. doi: 10.1038/ng1122. [DOI] [PubMed] [Google Scholar]
  8. Eidelman E, Chosack A, Rosenzweig KA. Hypodontia prevalence among Jewish populations of different origin. Am J Phys Anthrop. 1973;39:129–133. doi: 10.1002/ajpa.1330390113. [DOI] [PubMed] [Google Scholar]
  9. Ghassibe M, Bayet B, Revencu N, Verellen-Dumoulin C, Gillerot Y, Vanwijck R, Vikkula M. Interferon regulatory factor-6: A gene predisposing to isolated cleft lip with or without cleft palate in the Belgian population. Eur J Hum Genet. 2005;13:1239–1242. doi: 10.1038/sj.ejhg.5201486. [DOI] [PubMed] [Google Scholar]
  10. Graber L. Congenital absence of teeth: A review with emphasis on inheritance patterns. J Am Dent Assoc. 1978;96:266–275. doi: 10.14219/jada.archive.1978.0054. [DOI] [PubMed] [Google Scholar]
  11. Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB, Pebusque MJ. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33) Blood. 2000;95:1788–1796. [PubMed] [Google Scholar]
  12. Horvath S, Xu X, Laird NM. The family based association test method: Strategies for studying general genotype-phenotype associations. Eur J Hum Genet. 2001;9:301–306. doi: 10.1038/sj.ejhg.5200625. [DOI] [PubMed] [Google Scholar]
  13. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol. 2004;26:61–69. doi: 10.1002/gepi.10295. [DOI] [PubMed] [Google Scholar]
  14. Jones KL. Smith's recognizable patterns of human malformation. Philadelphia: W.B. Saunders; 1997. p. 857. [Google Scholar]
  15. Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Waranabe Y, Howard E, Lima RL, Daack-Hirsch S, Sander A, McDonald-McGinn DM, Zackai EH, Lammer EJ, Aylsworth AS, Ardinger HH, Lidral AC, Pober BR, Moreno L, Arcos-Burgos M, Valencia C, Houdayer C, Bahuau M, Moretti-Ferreira D, Richieri-Costa A, Dixon MJ, Murray JC. Mutations in interferon regulatory factor 6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet. 2002;32:285–289. doi: 10.1038/ng985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lammi L, Arte S, Somer M, Järvinen H, Lahermo P, Thesleff I, Pirinen S, Nieminen P. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet. 2004;74:1043–1050. doi: 10.1086/386293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Larson M, Hellquist R, Jakobsson OP. Dental abnormalities and ectopic eruption in patients with isolated cleft palate. Scand J Plast Reconstr Surg. 1998;32:203–212. doi: 10.1080/02844319850158831. [DOI] [PubMed] [Google Scholar]
  18. Lidral AC, Reising BC. The role of MSX1 in human tooth agenesis. J Dent Res. 2002;81:274–278. doi: 10.1177/154405910208100410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lopes LD, Mattos BSC, André M. Anomalies in number of teeth in patients with lip and/or palate clefts. Braz Dent J. 1991;2:9–17. [PubMed] [Google Scholar]
  20. Mossey PA, Little J. Epidemiology of oral clefts: An international perspective. In: Wyszynski DF, editor. Cleft lip and palate From origin to treatment. New York: Oxford; 2002. pp. 127–158. [Google Scholar]
  21. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet. 1994;8:269–274. doi: 10.1038/ng1194-269. [DOI] [PubMed] [Google Scholar]
  22. Quezada MGC, Hoeksma JB, van de Velde JP, Prahl-Andresen B, Kuijpers-Jagtman AM. Dental anomalies in patients with familial and sporadic cleft lip and palate. J Biol Buccale. 1998;16:185–190. [PubMed] [Google Scholar]
  23. Ranta R. Associations of some variables to tooth formation in children with isolated cleft palate. Scand J Dent Res. 1984;92:496–502. doi: 10.1111/j.1600-0722.1984.tb01288.x. [DOI] [PubMed] [Google Scholar]
  24. Ranta R. Numeric anomalies of teeth in concomitant hypodontia and hyperdontia. J Craniofac Genet Dev Biol. 1988;8:245–251. [PubMed] [Google Scholar]
  25. Ranta R, Tulensalo T. Symmetry and combinations of hypodontia in non-cleft and cleft palate children. Scand J Dent Res. 1988;96:1–8. doi: 10.1111/j.1600-0722.1988.tb01400.x. [DOI] [PubMed] [Google Scholar]
  26. Roth P, Hirschfelder U. Frequency of tooth agenesis in CLP patients with eruption of all four third molars. Dtsch Zahnarztl Z. 1991;46:734–736. [PubMed] [Google Scholar]
  27. Scapoli L, Palmieri A, Martinelli M, Pezetti F, Carinci P, Tognon M, Carinci F. Strong evidence of linkage disequilibrium between polymorphisms at the IRF6 locus and nonsyndromic cleft lip with or without cleft palate, in an Italian population. Am J Hum Genet. 2005;76:180–183. doi: 10.1086/427344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Slayton RL, Williams L, Murray JC, Wheeler JJ, Lidral AC, Nishimura CJ. Genetic association studies of cleft lip and/or palate with hypodontia outside the cleft region. Cleft Palate-Craniofac J. 2003;40:274–279. doi: 10.1597/1545-1569(2003)040<0274:GASOCL>2.0.CO;2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Srichomthong C, Siriwan P, Shotelersuk V. Significant association between IRF6 820G → A and non-syndromic cleft lip with or without cleft palate in the Thai population. J Med Genet. 2005;42:e46. doi: 10.1136/jmg.2005.032235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van den Boogaard MJH, Dorland M, Beemer FA, van Amstel HKP. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet. 2000;24:342–343. doi: 10.1038/74155. [DOI] [PubMed] [Google Scholar]
  31. Vichi M, Franchi L. Abnormalities of the maxillary incisors in children with cleft lip and palate. J Dent Child. 1995;62:412–417. [PubMed] [Google Scholar]
  32. Vieira AR. Oral clefts and syndromic forms of tooth agenesis as models for genetics of isolated tooth agenesis. J Dent Res. 2003;82:162–165. doi: 10.1177/154405910308200303. [DOI] [PubMed] [Google Scholar]
  33. Vieira AR, Meira R, Modesto A, Murray JC. MSX1, PAX9, and TGFA contribute to tooth agenesis in humans. J Dent Res. 2004;83:723–727. doi: 10.1177/154405910408300913. [DOI] [PubMed] [Google Scholar]
  34. White KE, Cabral JM, Davis SI, Fishburn T, Evans WE, Ichikawa S, Fields J, Yu X, Shaw NJ, McLellan NJ, McKeown C, Fitzpatrick D, Yu K, Ornitz DM, Econs MJ. Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet. 2005;76:361–367. doi: 10.1086/427956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zucchero T, Cooper ME, Maher BS, Daack-Hirsch S, Nepomuceno B, Ribeiro L, Caprau D, Christensen K, Suzuki Y, Machida J, Natsume N, Yoshiura K, Vieira AR, Orioli IM, Castilla EE, Moreno L, Arcos-Burgos M, idral AC, Field LL, Liu YE, Ray A, Goldstein TH, Schultz RE, Shi M, Johnson MK, Kondo S, Schutte BC, Marazita ML, Murray JC. Interferon regulatory factor (IRF6) is a modifier for isolated cleft lip and palate. New Engl J Med. 2004;351:769–780. doi: 10.1056/NEJMoa032909. [DOI] [PubMed] [Google Scholar]

RESOURCES